http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33488953

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, P.H.S.
endingPage 4977
issn 1091-6490
0027-8424
issueIdentifier 14
pageRange 4972-4977
publicationName Proceedings of the National Academy of Sciences of the United States of America
startingPage 4972
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_768db3a4df6b1f42c82cc90a33006e72
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6a7ca78ff11c254af62438be9cf14a1d
bibliographicCitation Lind MH, Rozell B, Wallin RP, van Hogerlinden M, Ljunggren HG, Toftgård R, Sur I. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Proc Natl Acad Sci U S A. 2004 Apr 06;101(14):4972–7. PMID: 15044707; PMCID: PMC387358.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d71a2517e8af06097ffecd990aa5e219
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d56d77ef7f6a28d0f53a31003f4ee439
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aec25b5b4cf8179f12b1f1a305c11a77
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a76ec8ee548056d69703b1e6f96c86a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ab41c80237ab5729b22e83ed2531b37
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e4b3530d1de3ce4749e2be1c7fb4c00
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75514b320f28ece7d2682dbb0d301771
date 2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1073/pnas.0307106101
https://pubmed.ncbi.nlm.nih.gov/15044707
https://pubmed.ncbi.nlm.nih.gov/PMC387358
isPartOf https://portal.issn.org/resource/ISSN/0027-8424
https://portal.issn.org/resource/ISSN/1091-6490
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6653
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition
discusses http://id.nlm.nih.gov/mesh/M0027090
http://id.nlm.nih.gov/mesh/M0539022
http://id.nlm.nih.gov/mesh/M0328543
http://id.nlm.nih.gov/mesh/M0027329
http://id.nlm.nih.gov/mesh/M0190194
http://id.nlm.nih.gov/mesh/M0022150
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015398Q000502
http://id.nlm.nih.gov/mesh/D012878Q000209
http://id.nlm.nih.gov/mesh/D018124Q000502
http://id.nlm.nih.gov/mesh/D002294Q000209
hasSubjectTerm http://id.nlm.nih.gov/mesh/D012878Q000503
http://id.nlm.nih.gov/mesh/D004817Q000503
http://id.nlm.nih.gov/mesh/D017931
http://id.nlm.nih.gov/mesh/D000072000
http://id.nlm.nih.gov/mesh/D002294Q000503
http://id.nlm.nih.gov/mesh/D006965
http://id.nlm.nih.gov/mesh/D020672Q000235
http://id.nlm.nih.gov/mesh/D008822
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D014409Q000502
http://id.nlm.nih.gov/mesh/D007150
http://id.nlm.nih.gov/mesh/D020133
http://id.nlm.nih.gov/mesh/D015854
http://id.nlm.nih.gov/mesh/D004817Q000473
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D001483
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6145b2f70a2b4510b96ed9f30b52f18f
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8094
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9245
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_be31966c8b098b5f6c016d466992c413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_243dda948625dacb43c134120aae43aa
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a24a0d100820c3a94d3a5def2bc5adc
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6891
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7172
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab84f5f64d92251f7a1ed6524bb44dfe
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21937
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16177
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25625

Total number of triples: 70.